Teva

OCTREOTIDE ACETATE

  1. Home
  2.  / 
  3. J Code
  4.  / OCTREOTIDE ACETATE – J2354

Manufacturer:

Teva

Name:

OCTREOTIDE ACETATE

HCPCS Code Descriptor:

Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg

Category:

J Code

HCPCS:

J2354

NDC(s):

00078-0180-01, 00078-0180-61, 00078-0181-01, 00078-0181-61, 00078-0182-01, 00078-0182-61, 67457-0246-01, 67457-0245-01, 67457-0239-01, 63323-0379-05, 63323-0378-05, 63323-0377-04, 63323-0377-01, 63323-0376-04, 63323-0376-01, 63323-0365-01, 63323-0365-04, 62756-0351-44, 62756-0352-40, 62756-0350-40, 62756-0348-44, 62756-0349-44, 62756-0094-44, 25021-0453-01, 25021-0454-05, 25021-0455-05, 25021-0451-01, 25021-0452-01, 23155-0689-41, 23155-0685-31, 23155-0686-31, 23155-0687-41, 23155-0688-41, 00703-3333-01, 00703-3343-01, 00703-3301-04, 00703-3311-04, 00703-3321-04, 00641-6177-01, 00641-6178-01, 00641-6176-10, 00641-6174-10, 00641-6175-10

Primary Type:

Growth Disorder

Generic Status:

Multi-Source

Route of Administration:

Injection

About:

OCTREOTIDE ACETATE is a Growth Disorder drug manufactured by Teva and administered via the Injection route of administration. The J Code: J2354 is aligned to the drug OCTREOTIDE ACETATE.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/04

HCPCS Effective Date:

1/1/04

HCPCS Short Description:

Octreotide inj, non-depot

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.novartis.us/our-products/patient-assistance/patient-assistance-foundation-enrollment

https://copay.novartisoncology.com/